Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia

NCT00832234 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

NETWORK

Sponsor class

Conditions

Waldenstroms Macroglobulinemia

Interventions

DRUG: Bortezomib, Dexamethasone, Rituximab

Sponsor

European Myeloma Network B.V.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]